
And because the drugs have already been approved by the U.

The 3-day inspection covered the Quality and Laboratory Control systems and included tours of all test laboratories and specialist analytical facilities including mass. The FDA late Friday approved Supernus Pharmaceuticals’ drug viloxazine for the treatment of ADHD patients 6 to 17 years of age. Registration simply means the FDA is aware of the manufacturer and their devices.


Contact a pharmacist with questions about your prescriptions, drug interactions, or concerns regarding your medications. The first nasal spray to treat dry eye disease has won approval from the US Food and Drug Administration (FDA).
